Bavarian Nordic's vaccine has potential to last longer than competition, says CEO

The world should be prepared for more Covid-19 jabs in the future, according to CEO of Bavarian Nordic Paul Chaplin, who highlights his company’s vaccine candidate as a bid for longer protection.
Photo: Philip Davali/Ekstra Bladet, Philip Davali
Photo: Philip Davali/Ekstra Bladet, Philip Davali
by marketwire, translated by daniel pedersen

Danish biotech firm Bavarian Nordic’s CEO, Paul Chaplin, says that having a vaccine that provides longer protection against Covid-19 would be an advantage, as reported by Danish business daily Børsen.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading